Form D · Pharmaceuticals
THREE RIVERS PHARMACEUTICALS LLC
Warrendale, PA · CIK 0001136392
Offering snapshot reported Apr 21, 2009 · SEC filing
- Reported sold
- $6.56M Offering amount: $10M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 21, 2009 | Amendment | $6,555,000 | No comparison | Not reported | SEC filing |
| Mar 3, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-40204
Source: Form D, filed Apr 21, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul F Fagan | Director, Executive, Promoter |
| Jeffrey Fisher | Director, Promoter |
| Donald J Kerrish | Director, Executive, Promoter |
| Patrick L Kerrish | Director, Executive, Promoter |
| Betty Sue Rich | Director, Promoter |
| Christine E Sheehy | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
119 Commonwealth Drive
Warrendale, PA, 15086
Warrendale, PA, 15086